Perceptron Announces New Robot Guidance Project Wins
Mar 08, 2018 21:15 pm UTC| Business
PLYMOUTH, Mich., March 08, 2018 -- Perceptron, Inc. (NASDAQ:PRCP), a leading global provider of 3D automated metrology solutions and coordinate measuring machines, today announced new In-Line Robot Guidance Solutions...
Post Holdings Announces Repricing of Approximately $2.2 Billion Term Loan
Mar 08, 2018 21:15 pm UTC| Business
ST. LOUIS, March 08, 2018 -- Post Holdings, Inc. (NYSE:POST) (the “Company” or “Post”) today announced it completed an opportunistic repricing of its existing approximately $2.2 billion term loan through an amendment to...
Funko Reports Fourth Quarter and Fiscal 2017 Financial Results
Mar 08, 2018 21:10 pm UTC| Business
EVERETT, Wash., March 08, 2018 -- Funko, Inc. ("Funko,” or the “Company”) (Nasdaq:FNKO), a leading pop culture consumer products company, today reported its financial results for the fourth quarter and fiscal year ended...
Mar 08, 2018 21:10 pm UTC| Business
ALAMEDA, Calif., March 08, 2018 -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today provided an update on the development and...
Research Frontiers Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 08, 2018 21:06 pm UTC| Business
Management to Host Conference Call at 4:30 p.m. WOODBURY, N.Y., March 08, 2018 -- Research Frontiers Inc. (Nasdaq:REFR) announced its financial results for its fourth quarter and full year ended December 31, 2017....
iPic® Entertainment Announces Initial Full Year 2018 Outlook
Mar 08, 2018 21:06 pm UTC| Business
Expects 2018 Comparable-Store Sales Growth of 0% to +5%Articulates Four Key Strategic Initiatives to Create Long-Term ValueCompany Reports Third Quarter 2017 Results and Expects to File 10-Q ShortlyReports Preliminary Full...
Atossa Genetics Announces 2017 Financial Results and Provides Company Update
Mar 08, 2018 21:06 pm UTC| Business
SEATTLE, March 08, 2018 -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announces...